The Dynamic Immune Signature of Patients with Advanced Non-small Cell Lung Cancer in Prediction of Infection After Receiving Immunotherapy
Journal of Thoracic Oncology(2022)
摘要
Pulmonary infection has been an important concern in patients with non-small cell lung cancer. It is well-known that chemotherapy may increase the infection rate by suppressing the immune system. Whether the clinical outcome of pulmonary infection is association with immunotherapy is still unclear. Mass cytometry is a next-generation flow cytometry platform with multiparametric analyses. Previous studies of mass cytometry showed that exhausted T cell were implicated in disease progression and response to immunotherapy.
更多查看译文
关键词
Non-small cell lung cancer, Immunotherapy, Immune signature
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要